Reducing Overdose After Release From Incarceration — ROAR  

Overdose, Drug Clinical Trial

Official title: Reducing Overdose After Release From Incarceration

Status Completed

Clinical Trial Summary

The primary objective of the ROAR project is to evaluate an Oregon Department of Corrections (ODOC) pilot program that combines the use of extended-release naltrexone (XR-NTX) and Certified Recovery Mentors pre-release with linkage to community substance use disorder treatment to prevent fatal and non-fatal opioid overdoses among female adults released from prison.

Clinical Trial Description

ROAR examines implementation of a novel overdose prevention strategy for justice-involved women as they re-enter community treatment settings after incarceration. The ODOC pilot project offers initiation of opioid antagonist treatment prior to release (extended-release naltrexone [XR-NTX]), ongoing support from a Certified Recovery Mentor (CRM), and facilitated entry into community treatment for substance use disorders. Community treatment may include continuation of XR-NTX,or transition to agonist therapy including buprenorphine or methadone, or no medication for opioid use disorder. ;

Related Conditions & MeSH terms

• Drug Overdose
• Overdose, Drug

• NCT number: NCT03902821
• Study type: Observational
• Source: Oregon Health and Science University
• Status: Completed
• Start date: June 17, 2019
• Completion date: November 30, 2023